Walter E. Washington Convention Center
Washington, D.C.
May 16-19, 2022

Gyros Protein Technologies

Warren,  NJ 
United States
  • Booth: 557

Gyros Protein Technologies provides enabling peptide synthesis and microfluidic immunoassay solutions to accelerate the discovery, development and manufacturing of safer cell and gene therapies.

Gyrolab® automated microfluidic, nanoliter-scale immunoassays offer 1 hour time to data using microliter sample volumes. Viral vector titer kits are available for AAVX, AAV9 (AAV) and p24 (lentivirus), and bioprocess impurity analysis solutions for HEK293 HCP and Endonuclease.


  • AAVX kit
    Ready-to-use Gyrolab kit for determination of AAV serotypes 1-8 and 10 viral particles in bioprocess and manufacturing samples of AAV viral vectors for cell and gene therapies.


  • Gyrolab® AAVX Titer Kit determines AAV vector titer in samples from process development and manufacturing in about an hour using only 8 µL of sample. The Gyrolab AAVX Titer Kit in combination with Gyrolab automated microfluidic immunoassay system delivers high quality, reproducible titer data for AAV serotypes 1–8 and AAVrh10 with better overall performance including 3-4 logs of assay dynamic range compared to ELISA. A Gyrolab AAV9 Kit is also available.